Proposed Data Collections Submitted for Public Comment and Recommendations, 75435-75436 [E8-29322]

Download as PDF Federal Register / Vol. 73, No. 239 / Thursday, December 11, 2008 / Notices You may submit all PRA comments by e-mail or U.S. post mail. To submit your comments by e-mail, send them to PRA@fcc.gov. To submit your comments by U.S. mail, mark them to the attention of Cathy Williams, Federal Communications Commission, Room 1–C823, 445 12th Street, SW., Washington, DC 20554. FOR FURTHER INFORMATION CONTACT: For additional information about the information collection(s), contact Cathy Williams at (202) 418–2918 or send an e-mail to PRA@fcc.gov. SUPPLEMENTARY INFORMATION: OMB Control Number: 3060–0161. Title: Section 73.61, AM Directional Antenna Field Strength Measurements. Form Number: Not applicable. Type of Review: Extension of a currently approved collection. Respondents: Business and other forprofit entities. Number of Respondents and Responses: 2,268. Estimated Time per Response: 1–4 hours. Frequency of Response: Recordkeeping requirement. Total Annual Burden: 36,020 hours. Total Annual Costs: None. Obligation to Respond: Required to obtain or retain benefits. The statutory authority for this information collection is contained in Sections 154(i) and 303 of the Communications Act of 1934, as amended. Nature and Extent of Confidentiality: There is no need for confidentiality with this collection of information. Privacy Impact Assessment(s): No impact(s). Needs and Uses: 47 CFR 73.61 requires that each AM station using directional antennas to make field strength measurement as often as necessary to ensure proper directional antenna system operation. Stations not having approved sampling systems make field strength measurements every three months. Stations with approved sampling systems must take field strength measurements as often as necessary. Also, all AM stations using directional signals must take partial proofs of performance as often as necessary. The FCC staff used the data in field inspections/investigations. AM licensees with directional antennas use the data to ensure that adequate interference protection is maintained between stations and to ensure proper operation of antennas. mstockstill on PROD1PC66 with NOTICES ADDRESSES: FEDERAL MARITIME COMMISSION Meetings; Sunshine Act AGENCY HOLDING THE MEETING: Federal Maritime Commission. TIME AND DATE: December 17, 2008— 10 a.m. PLACE: 800 North Capitol Street, NW., First Floor Hearing Room, Washington, DC. STATUS: A portion of the meeting will be in Open Session and the remainder of the meeting will be in Closed Session. MATTERS TO BE CONSIDERED: Open Session (1) Budget Status Report. Closed Session (1) FMC Agreement No. 201199—Port Fee Services Agreement. (2) Staff Briefing Regarding Global Economic Downturn and Potential Impact on Stakeholders—Possible Update. (3) Internal Administrative Practices and Personnel Matters. CONTACT PERSON FOR MORE INFORMATION: Tanga S. FitzGibbon, Alternate Federal Register Liaison Officer, (202) 523–5725. Tanga S. FitzGibbon, Alternate Federal Register Liaison Officer. [FR Doc. E8–29462 Filed 12–9–08; 4:15 pm] BILLING CODE 6730–01–P HARRY S. TRUMAN SCHOLARSHIP FOUNDATION Sunshine Act Meeting; Meeting of the Trustees and Officers of the Harry S. Truman Scholarship Foundation December 16, 2008, 9:30 a.m.–11:30 p.m. U.S. Capitol, RHOB, Room 2212. I. Call to order, Welcome, Approval of the Minutes from September 18, 2007 meeting. II. Approval of Selection of 2008 Truman Scholars. III. Executive Secretary Report: Development Fund. IV. Report on 2008–2009 TrumanAlbright Fellows program. V. Approval of a FY2009 Budget. VI. Old Business. VII. New Business. VIII. Adjournment. Federal Communications Commission. Marlene H. Dortch, Secretary. [FR Doc. E8–29371 Filed 12–10–08; 8:45 am] Dated: December 8, 2008. Frederick G. Slabach, Executive Secretary. [FR Doc. E8–29421 Filed 12–9–08; 11:15 am] BILLING CODE 6712–01–P BILLING CODE 6820–AD–P VerDate Aug<31>2005 17:27 Dec 10, 2008 Jkt 217001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 75435 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–09–0530] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 or send comments to Maryam Daneshvar, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of Information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments must be received within 60 days of this notice. Project Proposal Energy Employees Occupational Illness Compensation Program Act Dose Reconstruction Interviews and Forms, (OMB No. 0920–0530)—Extension—The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). Background and Brief Description On October 30, 2000, the Energy Employees Occupational Illness Compensation Program Act of 2000 (42 U.S.C. 7384–7385) was enacted. This Act established a federal compensation program for employees of the Department of Energy (DOE) and certain of its contractors, subcontractors and vendors, who have suffered cancers and other designated illnesses as a result of exposures sustained in the production and testing of nuclear weapons. E:\FR\FM\11DEN1.SGM 11DEN1 75436 Federal Register / Vol. 73, No. 239 / Thursday, December 11, 2008 / Notices Executive Order 13179, issued on December 7, 2000, delegated authorities assigned to ‘‘the President’’ under the Act to the Departments of Labor, Health and Human Services, Energy and Justice. The Department of Health and Human Services (DHHS) was delegated the responsibility of establishing methods for estimating radiation doses received by eligible claimants with cancer applying for compensation. NIOSH is applying the following methods to estimate the radiation doses of individuals applying for compensation. In performance of its dose reconstruction responsibilities, under the Act, NIOSH is providing voluntary interview opportunities to claimants (or their survivors) individually and providing them with the opportunity to assist NIOSH in documenting the work history of the employee by characterizing the actual work tasks performed. In addition, NIOSH and the claimant may identify incidents that may have resulted in undocumented radiation exposures, characterizing radiological protection and monitoring practices, and identify co-workers and other witnesses as may be necessary to confirm undocumented information. In this process, NIOSH uses a computer assisted telephone interview (CATI) system, which allows interviews to be conducted more efficiently and quickly as opposed to a paper-based interview instrument. Both interviews are voluntary and failure to participate in either or both interviews will not have a negative effect on the claim, although voluntary participation may assist the claimant by adding important information that may not be otherwise available. NIOSH uses the data collected in this process to complete an individual dose reconstruction that accounts, as fully as possible, for the radiation dose incurred by the employee in the line of duty for DOE nuclear weapons production programs. After dose reconstruction, NIOSH also performs a brief, voluntary final interview with the claimant to explain the results and to allow the claimant to confirm or question the records NIOSH has compiled. This will also be the final opportunity for the claimant to supplement the dose reconstruction record. At the conclusion of the dose reconstruction process, the claimant submits a form to confirm that the claimant has no further information to provide to NIOSH about the claim at this time. The form notifies the claimant that signing the form allows NIOSH to forward a dose reconstruction report to Department of Labor (DOL) and to the claimant, and closes the record on data used for the dose reconstruction. Signing this form does not indicate that the claimant agrees with the outcome of the dose reconstruction. The dose reconstruction results will be supplied to the claimant and to the DOL, the agency that will utilize them as one part of its determination of whether the claimant is eligible for compensation under the Act. There is no cost to respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent Number of responses per respondent Average burden (in hours) Total response burden hours Initial interview ................................................................................................. Conclusion Form .............................................................................................. 4,200 8,400 1 1 1 5/60 4,200 700 Total .......................................................................................................... ........................ ........................ ........................ 4,900 Dated: December 5, 2008. Maryam I. Daneshvar, Acting Reports Clearance Officer, Office of the Chief Science Officer, Centers for Disease Control and Prevention. [FR Doc. E8–29322 Filed 12–10–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention mstockstill on PROD1PC66 with NOTICES Centers for Disease Control and Prevention/Health Resources and Services Administration (CDC/HRSA) Advisory Committee on HIV and STD Prevention and Treatment This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the CDC/ HRSA Advisory Committee on HIV and STD Prevention and Treatment, Department of Health and Human Services, has been renewed for a 2-year period through November 25, 2010. VerDate Aug<31>2005 17:27 Dec 10, 2008 Jkt 217001 FOR FURTHER INFORMATION CONTACT: contact Kevin Fenton, M.D., Ph.D., Executive Secretary, CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment, Department of Health and Human Services, 1600 Clifton Road, NE., Mailstop E07, Atlanta, Georgia 30333, telephone (404) 639–8000 or fax (404) 639–8600. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: December 4, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–29325 Filed 12–10–08; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2007–D–0429] (formerly Docket No. 2007D–0496) Draft Guidance for Industry on Questions and Answers Regarding the Labeling of Nonprescription Human Drug Products Marketed Without an Approved Application as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act: Revision 1; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the availability of a revised draft guidance entitled ‘‘Questions and Answers Regarding the Labeling of Nonprescription Human Drug Products Marketed Without an Approved Application as Required by the Dietary Supplement and Nonprescription Drug E:\FR\FM\11DEN1.SGM 11DEN1

Agencies

[Federal Register Volume 73, Number 239 (Thursday, December 11, 2008)]
[Notices]
[Pages 75435-75436]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-29322]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-09-0530]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 or 
send comments to Maryam Daneshvar, CDC Acting Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
Information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments must be received 
within 60 days of this notice.

Project Proposal

    Energy Employees Occupational Illness Compensation Program Act Dose 
Reconstruction Interviews and Forms, (OMB No. 0920-0530)--Extension--
The National Institute for Occupational Safety and Health (NIOSH), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    On October 30, 2000, the Energy Employees Occupational Illness 
Compensation Program Act of 2000 (42 U.S.C. 7384-7385) was enacted. 
This Act established a federal compensation program for employees of 
the Department of Energy (DOE) and certain of its contractors, 
subcontractors and vendors, who have suffered cancers and other 
designated illnesses as a result of exposures sustained in the 
production and testing of nuclear weapons.

[[Page 75436]]

    Executive Order 13179, issued on December 7, 2000, delegated 
authorities assigned to ``the President'' under the Act to the 
Departments of Labor, Health and Human Services, Energy and Justice. 
The Department of Health and Human Services (DHHS) was delegated the 
responsibility of establishing methods for estimating radiation doses 
received by eligible claimants with cancer applying for compensation. 
NIOSH is applying the following methods to estimate the radiation doses 
of individuals applying for compensation.
    In performance of its dose reconstruction responsibilities, under 
the Act, NIOSH is providing voluntary interview opportunities to 
claimants (or their survivors) individually and providing them with the 
opportunity to assist NIOSH in documenting the work history of the 
employee by characterizing the actual work tasks performed. In 
addition, NIOSH and the claimant may identify incidents that may have 
resulted in undocumented radiation exposures, characterizing 
radiological protection and monitoring practices, and identify co-
workers and other witnesses as may be necessary to confirm undocumented 
information. In this process, NIOSH uses a computer assisted telephone 
interview (CATI) system, which allows interviews to be conducted more 
efficiently and quickly as opposed to a paper-based interview 
instrument. Both interviews are voluntary and failure to participate in 
either or both interviews will not have a negative effect on the claim, 
although voluntary participation may assist the claimant by adding 
important information that may not be otherwise available.
    NIOSH uses the data collected in this process to complete an 
individual dose reconstruction that accounts, as fully as possible, for 
the radiation dose incurred by the employee in the line of duty for DOE 
nuclear weapons production programs. After dose reconstruction, NIOSH 
also performs a brief, voluntary final interview with the claimant to 
explain the results and to allow the claimant to confirm or question 
the records NIOSH has compiled. This will also be the final opportunity 
for the claimant to supplement the dose reconstruction record.
    At the conclusion of the dose reconstruction process, the claimant 
submits a form to confirm that the claimant has no further information 
to provide to NIOSH about the claim at this time. The form notifies the 
claimant that signing the form allows NIOSH to forward a dose 
reconstruction report to Department of Labor (DOL) and to the claimant, 
and closes the record on data used for the dose reconstruction. Signing 
this form does not indicate that the claimant agrees with the outcome 
of the dose reconstruction. The dose reconstruction results will be 
supplied to the claimant and to the DOL, the agency that will utilize 
them as one part of its determination of whether the claimant is 
eligible for compensation under the Act.
    There is no cost to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of
               Type of respondent                    Number of     responses per  Average burden  Total response
                                                    respondents     respondent      (in hours)     burden hours
----------------------------------------------------------------------------------------------------------------
Initial interview...............................           4,200               1               1           4,200
Conclusion Form.................................           8,400               1            5/60             700
                                                 ---------------------------------------------------------------
    Total.......................................  ..............  ..............  ..............           4,900
----------------------------------------------------------------------------------------------------------------


    Dated: December 5, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Office of the Chief Science Officer, 
Centers for Disease Control and Prevention.
[FR Doc. E8-29322 Filed 12-10-08; 8:45 am]
BILLING CODE 4163-18-P